Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.

@article{Patti2007AtorvastatinPI,
  title={Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.},
  author={Giuseppe Patti and Vincenzo Pasceri and Giuseppe Colonna and Marco Miglionico and Dionigi Fischetti and Gennaro Sardella and Antonio Montinaro and Germano Di Sciascio},
  journal={Journal of the American College of Cardiology},
  year={2007},
  volume={49 12},
  pages={1272-8}
}
OBJECTIVES This study sought to investigate potential protective effects of atorvastatin in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI). BACKGROUND Randomized studies have shown that pretreatment with atorvastatin may reduce periprocedural myocardial infarction in patients with stable angina during… CONTINUE READING